795 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Rank Status Study
21 Unknown  Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
22 Unknown  Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Conditions: Depression;   Antidepressant Drug Adverse Reaction
Interventions: Drug: SSRI class antidepressant;   Drug: non-SSRI class antidepressant
23 Withdrawn Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Cetuximab
24 Completed EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Efavirenz
25 Completed
Has Results
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
Condition: Blood Clotting
Interventions: Genetic: warfarin pharmacogenetic dosing;   Drug: Warfarin
26 Completed Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia
Conditions: Pregnancy;   Cesarean Delivery;   General Anesthesia
Intervention: Drug: Remifentanil
27 Unknown  Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
Condition: Depression
Intervention: Drug: antidepressants
28 Completed CYP2D6 Pharmacogenetics in Risperidone-Treated Children
Conditions: Psychiatric Disorders;   Neurodevelopmental Disorders
Intervention:
29 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
30 Completed
Has Results
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Conditions: Idiopathic Growth Hormone Deficiency;   Turner Syndrome
Intervention: Other: Blood sampling
31 Unknown  Pharmacogenomics of Thiazolidinediones
Condition: Type 2 Diabetes
Intervention: Drug: Pioglitazone
32 Completed
Has Results
Pharmacogenomic Evaluation of Antihypertensive Responses
Condition: Hypertension
Interventions: Drug: HCTZ + atenolol;   Drug: Atenolol + HCTZ
33 Completed
Has Results
Clopidogrel Pharmacogenomics Project
Condition: Disease Susceptibility
Interventions: Drug: clopidogrel 75 mg;   Drug: Clopidogrel 150 mg
34 Completed Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
Intervention:
35 Completed Pharmacogenetics of b2-Agonists in Asthma.
Condition: Asthma
Interventions: Drug: fluticasone;   Drug: Salmeterol;   Drug: Ipratropium bromide
36 Completed Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
Intervention:
37 Active, not recruiting Pharmacogenetics, Emotional Reactivity and Smoking
Conditions: Tobacco Use Disorder;   Smoking Cessation
Interventions: Drug: Bupropion;   Drug: Varenicline;   Drug: Placebo;   Behavioral: Smoking Cessation Counseling
38 Completed
Has Results
Study of Medical Treatment for Methamphetamine Addiction
Conditions: Methamphetamine;   Amphetamine Dependence;   Pharmacogenetics;   Methamphetamine Dependence;   Substance Abuse
Intervention: Drug: Bupropion
39 Recruiting Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
Condition: Genetics of Drug Metabolism
Intervention:
40 Completed Clinical Pharmacogenomics of Antidepressant Response
Condition: Depression
Interventions: Drug: Paroxetine (Seroxat);   Drug: Escitalopram (Lexapro)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years